Jacobs Bruce N.
Chief Financial Officer at KYMR
- Sold, on record
- $18.7M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Jun 30, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KYMRKymera Therapeutics, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KYMRUnusualJan 12, 2022 2022
Sold 15,000 shares at $51.84 ($778k)
Jacobs Bruce N., Chief Financial Officer
Sold 46.1% of holdings ($1.7M position)17,514 shares left1.5x usual sizeFiling
- 2 Form 4 sale KYMRPlan not statedMar 2, 2023 +414 days
Sold 1,370 shares at $31.00 ($42k)
Jacobs Bruce N., Chief Financial Officer
Sold 1.3% of holdings ($3.3M position)104,568 shares left0.1x usual sizeFiling
- 3 Form 4 sale KYMRNo planMar 4, 2024 +368 days
Sold 3,934 shares at $41.85 ($165k)
Jacobs Bruce N., Chief Financial Officer
No 10b5-1 planSold 2.7% of holdings ($6.1M position)142,351 shares leftFollows a Form 144Filing
- 4 Form 144 notice KYMRNoticeMar 4, 2024 same day
Filed to sell 3,934 shares ($171k)
Jacobs Bruce N., Officer
No 10b5-1 planFiling
- 5 Form 4 sale KYMRNo planMar 3, 2025 +364 days
Sold 7,035 shares at $30.45 ($214k)
Jacobs Bruce N., Chief Financial Officer
No 10b5-1 planSold 3.4% of holdings ($6.4M position)201,886 shares leftFiling
- 6 Form 4 sale KYMRRoutineSep 17, 2025 +198 days
Sold 79,220 shares at $50.00 ($4M)
Jacobs Bruce N., Chief Financial Officer
10b5-1 planSold 25.8% of holdings ($15.3M position)227,409 shares leftFiling
- 7 Form 4 sale KYMRNo planMar 4, 2026 +168 days
Sold 12,471 shares at $87.50 ($1.1M)
Jacobs Bruce N., Chief Financial Officer
No 10b5-1 planSold 5.1% of holdings ($21.4M position)232,588 shares left1.8x usual sizeFiling
- 8 Form 4 sale KYMRUnusualJun 30, 2026 +118 days
Sold 77,109 shares at $114.97 ($8.9M)
Jacobs Bruce N., Chief Financial Officer
10b5-1 planSold 23.9% of holdings ($37M position)244,883 shares left6.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 2, 2026 | KYMR | Chief Financial Officer | Form 4 sale | 77,109 | $8.9M | 23.9% | Unusual | SEC |
| Mar 4, 2026 | Mar 4, 2026 | KYMR | Chief Financial Officer | Form 4 sale | 12,471 | $1.1M | 5.1% | No plan | SEC |
| Sep 17, 2025 | Sep 17, 2025 | KYMR | Chief Financial Officer | Form 4 sale | 79,220 | $4M | 25.8% | Routine | SEC |
| Mar 3, 2025 | Mar 3, 2025 | KYMR | Chief Financial Officer | Form 4 sale | 7,035 | $214k | 3.4% | No plan | SEC |
| Mar 4, 2024 | Mar 4, 2024 | KYMR | Officer | Form 144 notice | 3,934 | $171k | Notice | SEC | |
| Mar 4, 2024 | Mar 4, 2024 | KYMR | Chief Financial Officer | Form 4 sale | 3,934 | $165k | 2.7% | No plan | SEC |
| Mar 2, 2023 | Mar 3, 2023 | KYMR | Chief Financial Officer | Form 4 sale | 1,370 | $42k | 1.3% | Plan not stated | SEC |
| Jan 12, 2022 | Jan 14, 2022 | KYMR | Chief Financial Officer | Form 4 sale | 15,000 | $778k | 46.1% | Unusual | SEC |
| Dec 3, 2021 | Dec 3, 2021 | KYMR | Chief Financial Officer | Form 4 sale | 10,000 | $536k | 36.3% | Unusual | SEC |
| Sep 3, 2021 | Sep 3, 2021 | KYMR | Chief Financial Officer | Form 4 sale | 10,000 | $601k | 58.0% | Unusual | SEC |
| Jun 3, 2021 | Jun 4, 2021 | KYMR | Chief Financial Officer | Form 4 sale | 10,000 | $469k | 58.0% | Unusual | SEC |
| Mar 15, 2021 | Mar 15, 2021 | KYMR | Chief Financial Officer | Form 4 sale | 10,000 | $602k | 100.0% | Unusual | SEC |
| Mar 8, 2021 | Mar 8, 2021 | KYMR | Chief Financial Officer | Form 4 sale | 10,000 | $506k | 100.0% | Unusual | SEC |
| Mar 3, 2021 | Mar 5, 2021 | KYMR | Chief Financial Officer | Form 4 sale | 20,000 | $896k | 100.0% | Unusual | SEC |